Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Metabolic abnormalities of the heart in type II diabetes.

Amaral N, Okonko DO.

Diab Vasc Dis Res. 2015 Jul;12(4):239-48. doi: 10.1177/1479164115580936. Epub 2015 May 4. Review.

PMID:
25941161
2.

Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.

Ussher JR, Keung W, Fillmore N, Koves TR, Mori J, Zhang L, Lopaschuk DG, Ilkayeva OR, Wagg CS, Jaswal JS, Muoio DM, Lopaschuk GD.

J Pharmacol Exp Ther. 2014 Jun;349(3):487-96. doi: 10.1124/jpet.114.214197. Epub 2014 Apr 3.

3.

Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.

Wenmeng W, Qizhu T.

Med Hypotheses. 2011 Feb;76(2):181-3. doi: 10.1016/j.mehy.2010.09.012. Epub 2010 Oct 6.

PMID:
20932648
4.

Effects of metabolic approach in diabetic patients with coronary artery disease.

Fragasso G, Salerno A, Spoladore R, Cera M, Montanaro C, Margonato A.

Curr Pharm Des. 2009;15(8):857-62. Review.

PMID:
19275650
5.

Metabolic therapy for patients with diabetes mellitus and coronary artery disease.

Rosano GM, Vitale C, Fragasso G.

Am J Cardiol. 2006 Sep 4;98(5A):14J-18J. Epub 2006 Jul 24. Review.

PMID:
16931201
6.

["Persistent" angina: rationale for a metabolic approach].

Marzilli M.

Ital Heart J. 2004 Mar;5 Suppl 2:37S-41S. Review. Italian.

PMID:
15074776
7.

Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.

Am Heart J. 2003 Nov;146(5):E18.

PMID:
14597947
8.

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.

Rupp H, Zarain-Herzberg A, Maisch B.

Herz. 2002 Nov;27(7):621-36. Review.

PMID:
12439634
9.

[Modifications in myocardial energy metabolism in diabetic patients]].

Grynberg A.

Diabetes Metab. 2001 Nov;27(5 Pt 2):S12-9. French.

PMID:
11910980
10.

Clinical benefits of a metabolic approach in the management of coronary patients.

Marzilli M.

Rev Port Cardiol. 2000 Nov;19 Suppl 5:V25-30. Review.

PMID:
11206100

Supplemental Content

Loading ...
Support Center